Heat Biologics, Inc. carries a market capitalization of 61.07M, placing it among publicly traded companies globally.
| Market Cap | 61.07M |
| Enterprise Value | N/A |
Heat Biologics, Inc.'s stock has declined approximately -11.52416% over the past 52 weeks. The 50-day moving average sits at 2.57, while the 200-day moving average is 4.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.52416% |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | 4.11 |
| Average Volume (20 Days) | N/A |
Heat Biologics, Inc.'s most recent stock split took place on December 11, 2020 with a 7:1 split ratio.
| Last Split Date | 12/11/2020 |
| Split Ratio | 7:1 |